The prevalence of human herpesvirus 8 in normal, premalignant, and malignant cervical samples of Iranian women

Virol J. 2021 Jul 10;18(1):144. doi: 10.1186/s12985-021-01614-z.

Abstract

Background: Regard to this fact that the main transmission route of HPV and HHV-8 is via sexual activity, it is reasonable to speculate that coinfection of HPV and HHV-8 may have been played an important role in the development of cervical cancer. The aim of this study was to estimate the prevalence of HHV-8 and the frequency of HPV and HHV-8 coinfection in cervical samples of patients with cervical cancer and healthy individuals.

Methods: In total, 364 samples from 61 patients with cervical cancer, 124 women with premalignant lesions, and 179 healthy individuals were investigated by nested-PCR.

Results: The frequency of HHV-8 was found to be 22.9%, 17.7%, and 14.5% in cervical cancer, premalignant lesions, and normal specimens, respectively (P = 0.308). The overall prevalence of coinfection between HHV-8 and HPV was shown to be 16.2%. The HPV prevalence was higher in HHV-8 positive samples than HHV-8 negative specimens in all three studied groups and this difference was reached a statistically significant level (P = 0.002). However, no significant differences were found between HHV-8 positivity and HPV genotypes (P = 0.08).

Conclusions: Our results showed the higher rate of HHV-8 genome detection in cervical cancer group than control group. However, future studies with larger sample sizes and evaluation of expression of HHV-8 proteins are warranted.

Keywords: Cervical cancer; Genotypes; Human herpesvirus 8; Human papillomavirus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Coinfection* / epidemiology
  • Coinfection* / virology
  • DNA, Viral / genetics
  • Female
  • Herpesvirus 8, Human*
  • Humans
  • Iran / epidemiology
  • Papillomaviridae / genetics
  • Papillomavirus Infections* / complications
  • Papillomavirus Infections* / epidemiology
  • Precancerous Conditions* / epidemiology
  • Precancerous Conditions* / virology
  • Prevalence
  • Uterine Cervical Neoplasms* / epidemiology
  • Uterine Cervical Neoplasms* / virology

Substances

  • DNA, Viral